Global B2B Pharmaceutical Sourcing ยท Dossier Licensing ยท Named-Patient Access
๐Ÿ’ฌ WhatsApp ยท Sign in ยท Register

Oncology Cancer Care โ€” Manufacturers, Suppliers & Exporters

Can't find the Oncology Cancer Care product you need?
Send us an RFP โ€” our team sources it from verified manufacturers and reverts with quotes.
Send RFP โ†’

Browse Oncology Cancer Care products

Gemcitabine

Strength: 200 mg, 1000 mg, 1500 mg

Form: Lyophilized powder for solution for injection/infusion

Reference Brands: Gemzarยฎ (US & EU)

View Details Get Enquiry

Gemcitabine hydrochloride

Strength: 200โ€ฏmg, 1โ€ฏg, 2โ€ฏg

Form: Injection

Reference Brands: Gemzar (USA), Infugem (USA), Avgemsi (USA)

View Details Get Enquiry

Gemtuzumab Ozogamicin

Strength: 4.5 mg

Form: Injection

Reference Brands: Mylotarg (USA)

View Details Get Enquiry

Gilteritinib

Strength: 40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details Get Enquiry

Glasdegib maleate

Strength: 25 mg, 100 mg

Form: Tablets

Reference Brands: Daurismo (USA/EU)

View Details Get Enquiry

Glofitamab-gxbm

Strength: 1 mg/mL

Form: Injection

Reference Brands: Columvi (USA/EU)

View Details Get Enquiry

Granisetron Hydrochloride

Strength: Injection: 1 mg/mL, 3 mg/3 mL; Oral Tablet : 1 mg

Form: Injection (IV/SC), Oral Tablet

Reference Brands: Kytrilยฎ (US & EU)

View Details Get Enquiry

Histrelin Acetate

Strength: 50 mg

Form: Subcutaneous implant

Reference Brands: Vantas (USA), Supprelin LA (USA)

View Details Get Enquiry

Ibrutinib Capsules and tablets

Strength: Capsule:140 mg, 70 mg; Tablet: 140 mg

Form: Capsules and tablets

Reference Brands: Imbruvicaยฎ(US & EU)

View Details Get Enquiry

Idarubicin Hydrochloride

Strength: 5 mg/5 mL

Form: Injection

Reference Brands: Idamycin (USA)

View Details Get Enquiry

Idelalisib

Strength: 100 mg, 150 mg

Form: Tablets

Reference Brands: Zydelig (EU/UK/India)

View Details Get Enquiry

Ifosfamide

Strength: 1 g/vial,2 g/vial, 3 g/vial

Form: Injection

Reference Brands: Ifexยฎ (US), Holoxanยฎ (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.